# Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation.

Study · id `cardio:ct-nct07807423` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07807423](<https://clinicaltrials.gov/study/NCT07807423>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07807423

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 125 participants.

## Technical summary

Registry record NCT07807423. Allocation not applicable; no masking; primary purpose diagnostic. Start 2026-09-22 (actual); primary completion 2028-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 125 participants (planned count; ClinicalTrials.gov record NCT07807423, source copy `cardio:ctgov-nct07807423-2026-09-25`, retrieved 2026-10-26)
- Started: 2026-09-22 (actual) (ClinicalTrials.gov record NCT07807423, source copy `cardio:ctgov-nct07807423-2026-09-25`, retrieved 2026-10-26)
- Primary completion: 2028-02 (anticipated) (ClinicalTrials.gov record NCT07807423, source copy `cardio:ctgov-nct07807423-2026-09-25`, retrieved 2026-10-26)
- Completion: 2028-02 (anticipated) (ClinicalTrials.gov record NCT07807423, source copy `cardio:ctgov-nct07807423-2026-09-25`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT07807423, source copy `cardio:ctgov-nct07807423-2026-09-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07807423-2026-09-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Use of Volta Medical AI-software During Atrial Fibrillation Ablation to Identify Patients Who May Need More Than Pulmonary Vein Isolation.
- Acronym: DISPLAY-AF
- Condition: Atrial Fibrillation
- Intervention (Device): Complete biatrial mapping
- Lead sponsor: Volta Medical
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 11d470b948ed0f7c8edce77e5d2e07d72b0a995cda84d4ad2fd24e5688aec6cd
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
